TelyRx Holdings Inc. (TELY : TSX)
Common Stock
$2.45
CAD
-0.05 (-2.00%)
Last updated: 2026-07-13
TELY
TelyRx Holdings Inc.
WealthAwesomePerformance
1 Day
-2.00%
1 Week
+2.94%
1 Month
+6.52%
YTD
-30.00%
Key Statistics
Market Cap
$66.45M
52W High
$4.25
52W Low
$2.00
P/E Ratio
-
50 Day MA
$2.65
200 Day MA
$2.79
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/13/2026 | $2.48 | $2.70 | $2.35 | $2.45 | $2.45 | 7,200 |
| 7/10/2026 | $2.60 | $2.60 | $2.45 | $2.50 | $2.50 | 4,000 |
| 7/9/2026 | $2.50 | $2.50 | $2.45 | $2.50 | $2.50 | 6,766 |
| 7/8/2026 | $2.40 | $2.40 | $2.40 | $2.40 | $2.40 | 1,000 |
| 7/7/2026 | $2.40 | $2.40 | $2.40 | $2.40 | $2.40 | 200 |
| 7/6/2026 | $2.40 | $2.40 | $2.35 | $2.38 | $2.38 | 1,400 |
| 7/3/2026 | $2.45 | $2.45 | $2.35 | $2.35 | $2.35 | 3,300 |
| 7/2/2026 | $2.27 | $2.60 | $2.02 | $2.40 | $2.40 | 9,100 |
| 6/30/2026 | $2.52 | $2.52 | $2.37 | $2.37 | $2.37 | 800 |
| 6/29/2026 | $2.35 | $2.46 | $2.00 | $2.34 | $2.34 | 8,200 |
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 144.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+144.9% Upside
Current Price
C$2.45
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
83.1%
Annualized
90-Day Vol
92.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.31 | C$1.73 – C$3.07 |
| 60 trading days | C$2.18 | C$1.45 – C$3.26 |
| 90 trading days | C$2.05 | C$1.25 – C$3.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About TelyRx Holdings Inc.
TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida.
Financials
- Revenue (TTM)
- $55.39M
- EBITDA
- $-7.74M
- Profit Margin
- -18.17%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.58
- Book Value
- 0.75
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About TELY
Articles Featuring TELY.TO
Latest articles and analysis covering TELY.TO
Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. (TELY.TO) has experienced a significant 6.12% increase in stock price, driven by recent company milestones and an upcoming investor presentation that may solidify its market position.
Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. has experienced a significant stock increase today, driven by recent company milestones and upcoming investor engagement opportunities.
Why TelyRx Holdings Inc. stock is rising today
TelyRx Holdings Inc. has seen a 4.00% increase in its stock price, closing at CA$2.60, driven by excitement surrounding its upcoming presentation at the Global Technology Virtual Investor Conference.
Why TelyRx Holdings Inc. stock is gaining today
TelyRx Holdings Inc. has seen a 1.28% gain today, fueled by its recent financial results showing significant revenue growth. Investors are optimistic about the company's future, but caution is warranted due to ongoing net losses.
Why TelyRx Holdings Inc. stock is sliding today
TelyRx Holdings Inc. is down 2.08% today, closing at CA$2.35, as investors react to its ongoing financial struggles despite recent revenue growth.
Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. is experiencing a notable decline, with its stock falling by 9.28% in today's trading session. Investors are left questioning the stability of the company amidst a lack of recent news.
Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. stock took a hit today, closing down 8.24% as investors reacted to the company's increasing net losses despite revenue growth. With a market cap of CA$67.8 million, the stock's performance raises red flags for potential investors.
Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. saw its stock plummet by 17.65% today, closing at CA$2.10. Investors are left questioning the company's stability as it navigates a challenging market landscape.
Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. (TELY.TO) experienced a significant 6.22% increase in its stock price today, closing at CA$2.56. This upward movement comes in the wake of positive revenue announcements and strategic developments within the company.
Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. has seen a significant stock price increase of 6.22% today, driven by impressive revenue growth and an increase in prescriptions filled, though the company still faces financial challenges.
Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. experienced a significant drop in stock price today, raising questions about its financial viability despite recent revenue growth.
Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. experienced a significant stock price increase of 17.39% in the last trading session, closing at CA$2.70. This upward movement is a positive sign for investors, especially in light of the company's recent financial performance.
Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. has experienced a remarkable 10% increase in its stock price today, fueled by impressive revenue growth reported in its recent financial results. The company's strong performance in the healthcare sector positions it as a compelling investment opportunity.
Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. (TELY.TO) faced a significant setback in its stock performance, closing down 6.12% at CA$2.30. This decline follows a period of revenue growth but also highlights ongoing financial challenges, including a widening net loss.
Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. experienced a sharp decline in its stock price today, falling by 6.12% to CA$2.30. This drop comes despite recent reports of revenue growth, raising questions about the company's financial health and future prospects.
Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. shares jumped nearly 8% today, driven by anticipation surrounding its participation in an upcoming investor conference.
Why TelyRx Holdings Inc. stock is skyrocketing today
TelyRx Holdings Inc. has surged by 13.64% in a single trading day, driven by excitement surrounding its upcoming presentation at a virtual investor conference. This event could be pivotal for the company's future growth and investor engagement.
Why TelyRx Holdings Inc. stock is plummeting today
TelyRx Holdings Inc. saw a dramatic 17.55% drop in stock price today, closing at CA$2.02. Investors are left to ponder the implications of this decline as the company prepares for an important investor conference.
